Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Shutdown Realities At FDA: No New Submission Reviews, And More

This article was originally published in The Gray Sheet

Executive Summary

New PMA and 510(k) submissions, and anything else tied to an FY 2014 user fee payment, are not being reviewed by FDA as of Oct. 1. The limited carryover-FY 2013 user fees FDA has are supporting ongoing reviews, while the registration and listing and export certification database entry systems are unavailable.


Related Content

FDA Shutdown Plans For 2015: Same As 2013, But With More People
Request For Predictable NIH Funding Growth Met By Spending Caps
Request For Predictable NIH Funding Growth Met By Spending Caps
Director Collins Implores Congress To Set Predictable NIH Funding Growth
Budget Accord Should Increase FDA Funding, Free Up User Fees
People Briefs: Resignations At Cambridge Heart; Appointments At Sun Diagnostics, Cook Medical
News Briefs: Teleflex Acquires Vidacare; Integra Buys Covidien’s DuraSeal Line
Government Shutdown Causes Backlog Of 100 Device Submissions, With More Expected
Device Tax Repeal Gains High Profile During Shutdown, But Significant Barriers Remain
News Briefs: FDA Program Alignment Group; CardioMEMS Panel; HCV Coverage Analysis





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts